68P Phase II results of ivonescimab (ivo) a novel PD-1/VEGF bispecific in combination with chemotherapy for first-line treatment of patients (pts) with advanced/metastatic squamous (Sq) non-small cell lung cancer (NSCLC)

L. Zhang,W.F. Fang, Y. Zhao, Y. Yang, N. Zhou,L. Chen, Y. Huang, J. Chen, L. Zhuang, Y. Du, Q. Yu,W. Zhuang,Y. Zhao, M. Zhou,W. Zhang, Y. Zhang, Y. Wan, Y. Xia

ESMO Open（2024）

Cited 0|Views6

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined